Multimodal Imaging Analysis of Retinal and Microvascular Changes in Alport Syndrome - Top-Institutions - MDSpire

Multimodal Imaging Analysis of Retinal and Microvascular Changes in Alport Syndrome

  • By

  • Irem Kirci Dogan

  • Caner Incekas

  • Imren Akkoyun

  • Sezin Akca Bayar

  • Gursel Yilmaz

  • January 19, 2026

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts Eye and Ear Infirmary
    Massachusetts Eye and Ear Infirmary

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Retinal Imaging
    • Genetic Eye Diseases

  • #2

    Johns Hopkins Wilmer Eye Institute
    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Retinal Disease
    • Genetic Disorders

  • #3

    Moorfields Eye Hospital
    Moorfields Eye Hospital

    London, N/A

    Key Differentiators

    • Ophthalmology
    • Retinal Imaging
    • Genetic Eye Diseases

  • #4

    Bascom Palmer Eye Institute
    Bascom Palmer Eye Institute

    Miami, FL

    Key Differentiators

    • Ophthalmology
    • Retinal Imaging
    • Genetic Eye Diseases

  • #5

    National Eye Institute (NEI), NIH
    National Eye Institute (NEI), NIH

    Bethesda, MD

    Key Differentiators

    • Ophthalmology Research
    • Genetic Eye Disorders
    • Imaging Technologies

Original Source(s)

Multimodal Imaging Analysis of Retinal and Microvascular Changes in Alport Syndrome

  • by Irem Kirci Dogan, Caner Incekas, Imren Akkoyun, Sezin Akca Bayar, Gursel Yilmaz

  • January 19, 2026

Related Content

Evaluating Retinal Vascular Oxygen Saturation Levels in Myopic Children Versus Adults

Lutein Supplementation May Improve Outcomes in Early AMD

Meta-analysis found statistically significant improvements, with clearest benefits in early-stage disease

Myopia Severity Tied to Pediatric Retinal Pathology

Routine dilated examinations identified peripheral retinal abnormalities across refractive groups, with higher pathology rates among patients with at least 3.00 D of myopia